Medicare Enrolled
Anita Barikian
Ophthalmology · Stuart, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Barikian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Barikian?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Barikian
Anita Barikian is an ophthalmology specialist in Stuart, FL, with 10 years of NPI registration. Based on federal Medicare data, Barikian performed 20,876 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Barikian received a total of $9,932 from 25 pharmaceutical and/or device companies across 100 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Barikian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 10 years of NPI registration
▲ Top 6% volume in FL
$9,932 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗20,876
Medicare services
Top 6% in FL for ophthalmology
Not available
Unique patients (not deduplicated)
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye injection (Vabysmo/faricimab) An injection of faricimab-svoa, a medication administered in 0.1 mg doses. |
13,380 | $29 | $42 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
1,345 | $29 | $48 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,226 | $67 | $106 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,031 | $89 | $150 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
722 | $28 | $51 |
| Eye injection for retinal disease A procedure involving the administration of medication directly into the eye. |
645 | $95 | $155 |
| Aflibercept eye injection (Eylea) | 642 | $690 | $1,072 |
| Injection, ranibizumab, 0.1 mg | 472 | $179 | $386 |
| Visual field test, extended A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam. |
358 | $44 | $73 |
| Optic nerve imaging (OCT scan) Imaging of the optic nerve. |
327 | $25 | $44 |
| Microfluid analysis of tears A laboratory test that analyzes tear fluid using microfluidic technology to measure specific biomarkers. This procedure helps evaluate the composition of tears for diagnostic purposes. |
109 | $22 | $26 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
105 | $108 | $217 |
| Visual evoked potential test A test that measures how quickly electrical signals travel from the eye to the brain in response to visual stimuli. |
90 | $50 | $79 |
| Tear duct plug insertion A procedure to insert a small plug into the tear duct opening to help retain tears on the eye surface. |
71 | $163 | $293 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
71 | $860 | $1,197 |
| Ultrasound of eye tissue and structures A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures. |
47 | $38 | $59 |
| Retinal angiography with dye injection This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body. |
37 | $99 | $138 |
| Eyelash removal with forceps This procedure involves the manual removal of eyelashes using forceps. It is a mechanical extraction method performed on the eyelid area. |
34 | $11 | $27 |
| Eye drainage system examination An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye. |
26 | $17 | $32 |
| Retinal and optic nerve function test A diagnostic test that measures how well the retina and optic nerve are functioning. |
23 | $101 | $159 |
| Ultrasound of eye tissue and structures A non-invasive imaging test that uses sound waves to create pictures of the eye's internal tissues and structures. |
22 | $60 | $123 |
| Extended exam of back of eye with optic nerve drawing A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing. |
22 | $10 | $20 |
| Laser removal of recurring cataract A laser procedure to remove a recurring cataract within the lens capsule. |
21 | $267 | $395 |
| Ultrasound scan of cornea to determine thickness An ultrasound procedure used to measure the thickness of the cornea. |
20 | $9 | $17 |
| Extended eye exam with retinal drawing A detailed examination of the back of the eye that includes creating a drawing of the retina. |
19 | $17 | $30 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
11 | $74 | $145 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$9,932
Total received (2018-2024)
Avg $1,655/year across 6 years
Top 15% in FL for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
25
Companies
100
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,445
2023
$866
2022
$1,903
2021
$1,201
2020
$271
2018
$246
Payments by company (2024)
Regeneron Pharmaceuticals, Inc.
$3,792
Regeneron Healthcare Solutions, Inc.
$321
Astellas Pharma US Inc
$278
Alimera Sciences, Inc.
$212
Ocular Therapeutix, Inc.
$191
Genentech USA, Inc.
$188
Carl Zeiss Meditec USA, Inc.
$169
Apellis Pharmaceuticals, Inc.
$156
Bausch & Lomb Americas Inc.
$38
Dompe US, Inc.
$28
Oyster Point Pharma, Inc.
$25
Alcon Vision LLC
$25
Mallinckrodt Hospital Products Inc.
$22
Top 3 companies account for 80.6% of 2024 payments
All-time payments by company (2018-2024) ›
Regeneron Pharmaceuticals, Inc.
$3,861
Alimera Sciences, Inc.
$892
Apellis Pharmaceuticals, Inc.
$881
Genentech USA, Inc.
$828
Regeneron Healthcare Solutions, Inc.
$806
Astellas Pharma US Inc
$543
Allergan, Inc.
$342
Bausch & Lomb Americas Inc.
$329
Carl Zeiss Meditec USA, Inc.
$264
Alcon Vision LLC
$235
Carl Zeiss Meditec, Inc.
$215
Ocular Therapeutix, Inc.
$191
Dutch Ophthalmic, USA
$184
Novartis Pharmaceuticals Corporation
$52
AbbVie Inc.
$52
Oyster Point Pharma, Inc.
$46
Coherus Biosciences Inc.
$33
Dompe US, Inc.
$28
Johnson & Johnson Surgical Vision, Inc.
$27
Horizon Therapeutics plc
$27
Sun Pharmaceutical Industries Inc.
$24
Mallinckrodt Hospital Products Inc.
$22
ABBVIE INC.
$21
Aerie Pharmaceuticals, Inc.
$16
Bausch & Lomb, a division of Bausch Health US, LLC
$13
Top 3 companies account for 56.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · BEOVU · CIRRUS HD-OCT · Cequa · Cimerli · Constellation · DEXTENZA · DURYSTA · EVA Ophthalmic Surgical System · EYLEA · EYLEA HD · FORUM · ILUVIEN · Izervay · LOTEMAX SM · LUMIGAN · Lucentis · MIEBO · OXERVATE · OZURDEX · Rocklatan · Syfovre · TEPEZZA · TYRVAYA · Tecnis IOL · Vabysmo · XIPERE · YUTIQ · enVista MX60 IOL · rhopressa
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Ophthalmologists in nearby ZIP areas
46
County median income
$80,701
Nearest hospital to ZIP centroid (approximate)
CLEVELAND CLINIC MARTIN NORTH HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Barikian is a mixed practice specialist, with above-average Medicare volume (top 6% in FL).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Barikian experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Barikian performed 13,380 eye injection (vabysmo/faricimab) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Barikian receive payments from pharmaceutical companies?
Yes. Barikian received a total of $9,932 from 25 companies across 100 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Barikian's costs compare to other ophthalmologists in Stuart?
Barikian's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Barikian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Ophthalmologists in Stuart
Browse ophthalmologists in Stuart ranked by procedure volume and transparency data.
Highest volume
Top Ophthalmologists in FL
Ophthalmologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Ophthalmologists in FL
Which FL ophthalmologists receive the most from drug and device companies.
By company
Regeneron Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Pharmaceuticals, Inc.
By company
Alimera Sciences, Inc. Payments to Doctors
See all physicians who received payments from Alimera Sciences, Inc.
By company
Apellis Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Apellis Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology